ReviewCurrent opinion in infectious diseases2011
Invasive nontyphoidal Salmonella disease: epidemiology, pathogenesis and diagnosis.
Review in Current opinion in infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
101 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence, probability, and outcomes of typhoidal/non-typhoidal Salmonella and malaria co-infection among febrile patients: a systematic review and meta-analysis.Scientific reports · 2021Pooled it
- A combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial.Nature medicine · 2025Trial
- Multi-Omics and Functional Analysis ofToxins · 2026Article
- Invasive Non-typhoidalInfectious diseases & clinical microbiology · 2026Article
- Public health data collected by PulseNet support a role forMicrobiology spectrum · 2026Article
- Fatal Colonic Perforation Secondary to Non-typhoidal Salmonella Infection in an Immunocompetent Elderly Patient.Cureus · 2026Article
- Development of a GMMA-based candidate vaccine against invasive nontyphoidalFrontiers in immunology · 2026Article
- Bacterial-associated bloodstream infections among hospitalized patients in Lagos, Nigeria.BMC infectious diseases · 2025Article
- A phase 1 randomized, placebo-controlled trial of a combination typhoid and non-typhoidalmedRxiv : the preprint server for health sciences · 2025Article
- Effectiveness of iNTS vaccination in sub-Saharan Africa.Scientific reports · 2025Article
- Bacteriophages againstFrontiers in bioengineering and biotechnology · 2025Review
- Prevalence and Antimicrobial Resistance Diversity ofAntibiotics (Basel, Switzerland) · 2024Article
- Meningitis and Bacteremia by Unusual Serotype ofInterdisciplinary perspectives on infectious diseases · 2024Article
- Clinical-Microbiological Study of Nontyphoidal Salmonella Infections from Karnataka, India.Scientifica · 2024Article
- Anti-interferon-gamma autoantibody and salmonellosis: Case report and literature review.IDCases · 2024Article
- Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2023Article
- Vaccination and Trust in the National Health System among HIV+ Patients: An Italian Cross-Sectional Survey.Vaccines · 2023Article
- Human Salmonellosis: A Continuous Global Threat in the Farm-to-Fork Food Safety Continuum.Foods (Basel, Switzerland) · 2023Review
- Can Nanobubble Ozone Liposomes be a New Agent in the Fight Against Foodborne Infections?Recent patents on nanotechnology · 2023Article
- Antimicrobial resistance and virulence genes of invasiveSAGE open medicine · 2023Article
41 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
purpose of reviewThis review highlights and discusses important publications over the past 12 months providing new insights on invasive nontyphoidal Salmonella (iNTS) disease. RECENT
findingsThere have been informative new estimates of the burden of iNTS in Asia and in high-resource, low-incidence settings. Important information has emerged in the last year about the relationships between HIV, malaria, iNTS and typhoid fever in adults and children in Africa. HIV causes susceptibility to iNTS disease, but has been shown to be protective against typhoid fever. Clinical guidelines for presumptive diagnosis frequently fail to identify iNTS disease in Africa, and there remains a need for improved diagnostic tools. Experimental studies in humans have helped us to understand the intracellular pathogenesis of iNTS and to direct the search for appropriate protein vaccine targets. SUMMARY: The most important remaining gap in our knowledge is probably an understanding of how NTS is transmitted, and the nature of the relationship between diarrhoeal disease, carriage and invasive disease in Africa, so that diagnostic and prevention tools can be appropriately directed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.